HLA-mismatched donor and high ferritin level showed poor clinical outcomes after allogeneic hematopoietic cell transplantation in patients with advanced myelofibrosis

BACKGROUND: Preconditioning intensity, donor choice and graft-versus-host disease (GVHD) prophylaxis of allogeneic hematopoietic cell transplantation (allo-HCT) for advanced myelofibrosis (MF) have not been fully elucidated. METHODS: Thirty-five patients with advanced MF were treated with reduced-in...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Jae-Ho, Min, Gi June, Park, Sung-Soo, Park, Silvia, Lee, Sung-Eun, Cho, Byung-Sik, Kim, Yoo-Jin, Lee, Seok, Kim, Hee-Je, Min, Chang-Ki, Cho, Seok-Goo, Lee, Jong Wook, Eom, Ki-Seong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502801/
https://www.ncbi.nlm.nih.gov/pubmed/32994911
http://dx.doi.org/10.1177/2040620720936935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502801/
https://www.ncbi.nlm.nih.gov/pubmed/32994911
http://dx.doi.org/10.1177/2040620720936935

Ejemplares similares